PRECISVIEW

Serial Number 87818515
Registration 5807807
702

Registration Progress

Application Filed
Mar 2, 2018
Under Examination
Sep 25, 2018
Approved for Publication
Jul 31, 2018
Published for Opposition
Jul 31, 2018
Registered
Jul 16, 2019

Attorney Assistance

Section 8 Declaration Due (Principal Register) (Based on registration date 20190716) (Grace Period Filing)
Due: Jan 16, 2026 Grace Period - 15 days
Original deadline was Jul 16, 2025 (overdue)

Trademark Image

PRECISVIEW

Basic Information

Serial Number
87818515
Registration Number
5807807
Filing Date
March 2, 2018
Registration Date
July 16, 2019
Published for Opposition
July 31, 2018
Drawing Code
3

Status Summary

Current Status
Active
Status Code
702
Status Date
Sep 3, 2025
Registration
Registered
Classes
042

Rights Holder

PHENOMICS HEALTH INC.

03
Address
46701 Commerce Center Drive
Michigan Life Science & Innovation Ctr.
Plymouth, MI 48170

Ownership History

Sano Informed Prescribing, Inc.

Original Applicant
03
Franklin, TN

Sano Informed Prescribing, Inc.

Owner at Publication
03
Franklin, TN

PRECERA BIOSCIENCE, INC.

New Owner After Publication #1
03
FRANKLIN, TN

PRECERA BIOSCIENCE, INC.

Original Registrant
03
FRANKLIN, TN

PHENOMICS HEALTH INC.

New Owner After Registration #1
03
Plymouth, MI

Legal Representation

Attorney
Roger H. Bora

USPTO Deadlines

Next Deadline
In Grace Period
Section 8 Declaration Due (Principal Register) (Based on registration date 20190716)
Due Date
July 16, 2025
Grace Period Ends
January 16, 2026
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

33 events
Date Code Type Description Documents
Sep 3, 2025 NA85 E NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED Loading...
Sep 3, 2025 C15A O REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. Loading...
Sep 3, 2025 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL Loading...
Apr 25, 2025 E815 I TEAS SECTION 8 & 15 RECEIVED Loading...
Jul 16, 2024 REM1 E COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED Loading...
Oct 2, 2019 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Oct 2, 2019 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Sep 25, 2019 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Loading...
Jul 16, 2019 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Jun 14, 2019 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
Jun 13, 2019 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Jun 12, 2019 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Mar 25, 2019 IUAF S USE AMENDMENT FILED Loading...
Apr 9, 2019 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Mar 25, 2019 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Sep 25, 2018 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Jul 31, 2018 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jul 31, 2018 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jul 11, 2018 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jul 4, 2018 ASCK I ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY Loading...
Jun 27, 2018 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jun 26, 2018 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jun 25, 2018 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jun 25, 2018 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Jun 15, 2018 CEPE I COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION ENTERED Loading...
Jun 15, 2018 ALIE A ASSIGNED TO LIE Loading...
Jun 14, 2018 GEAN O NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED Loading...
Jun 14, 2018 GEAP F EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED Loading...
Jun 14, 2018 CPEA R EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED Loading...
Jun 14, 2018 DOCK D ASSIGNED TO EXAMINER Loading...
Mar 10, 2018 MDSM E NOTICE OF DESIGN SEARCH CODE E-MAILED Loading...
Mar 9, 2018 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Mar 6, 2018 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 042
Scientific and technological services featuring testing, analysis and evaluation of blood samples for the purpose of drug development by others, namely, data-driven analytics and reporting to developers of drugs; scientific and technological services featuring testing, analysis and evaluation of blood samples for the purpose of improving quality in the field of healthcare services, specifically for improving the monitoring and diagnostics of quantitative patient drug exposure, monitoring and diagnostics of patient drug compliance, data-driven analytics and reporting to providers of healthcare services in the field of pharmacovigilance activities, drug dosage recommendations, initial drug prescribing, and drug switching, all for research purposes and not for medical purposes
First Use Anywhere: Mar 25, 2019
First Use in Commerce: Mar 25, 2019

Additional Information

Design Mark
The mark consists of one word, "PRECISVIEW", beginning with a capital "P" and a punctuation mark over the first "I" as it appears in the word followed by a capital "V" for the word "VIEW".
Color Claim
Color is not claimed as a feature of the mark.
Pseudo Mark
PRECIS VIEW

Classification

International Classes
042